Does using daratumumab make response-monitoring difficult? International Myeloma Foundation 3:24 7 years ago 42 100 Далее Скачать
Treatment options for patients with multiple myeloma who are resistant to daratumumab VJHemOnc – Video Journal of Hematology & HemOnc 1:58 1 year ago 285 Далее Скачать
Response monitoring in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:18 3 years ago 413 Далее Скачать
Real-world daratumumab monotherapy VJHemOnc – Video Journal of Hematology & HemOnc 3:12 4 years ago 344 Далее Скачать
CyTOF flow cytometry in determining daratumumab response in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:27 5 years ago 181 Далее Скачать
TOTAL Therapy 7: high response rates in high risk NDMM to daratumumab VJHemOnc – Video Journal of Hematology & HemOnc 2:03 4 years ago 143 Далее Скачать
Dr. Usmani on Mechanisms and Response Rates With Daratumumab in Myeloma OncLive 1:15 7 years ago 137 Далее Скачать
Myeloma: Treatment Factors and Monitoring Response Targeted Oncology 3:56 6 years ago 77 Далее Скачать
When do you use daratumumab with lenalidomide/dexamethasone or bortezomib/dexamethasone in practice? MediCom Oncology 2:56 7 years ago 914 Далее Скачать
Promising results for daratumumab in the front line setting VJHemOnc – Video Journal of Hematology & HemOnc 2:42 6 years ago 310 Далее Скачать
Daratumumab with Ixazomib and Dex in Pts with One Prior Lenalidomide-Based Regimen: The DARIA Study International Myeloma Foundation 5:28 3 years ago 257 Далее Скачать
Daratumumab for the Treatment of Patients With Multiple Myeloma Targeted Oncology 3:15 9 years ago 80 Далее Скачать
Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learn... Multiple Myeloma Hub 13:25 2 years ago 154 Далее Скачать
How Professor Viklicky used Prospera to monitor treatment response in both ABMR and TCMR cases Natera 25:37 1 month ago 49 Далее Скачать
Efficacy and Safety of Daratumumab, Bortezomib, and Dex (D-Vd) Vs Vd in First Relapse Patients International Myeloma Foundation 2:36 5 years ago 186 Далее Скачать
A follow-up from the CASTOR trial evaluating daratumumab with bortezomib for the treatment of MM VJHemOnc – Video Journal of Hematology & HemOnc 2:09 7 years ago 156 Далее Скачать
Monitoring Response and Defining Complete Remission in Multiple Myeloma OncLive 4:40 9 years ago 836 Далее Скачать
Which patients will benefit the most from treatment with daratumumab and elotuzumab? MediCom Oncology 1:37 8 years ago 58 Далее Скачать
